Critical Analysis: Dynatronics (NASDAQ:DYNT) vs. Motus GI (NASDAQ:MOTS)

Dynatronics (NASDAQ:DYNT) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, profitability and dividends.

Insider & Institutional Ownership

11.7% of Dynatronics shares are owned by institutional investors. Comparatively, 43.3% of Motus GI shares are owned by institutional investors. 22.7% of Dynatronics shares are owned by company insiders. Comparatively, 18.1% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Dynatronics and Motus GI’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Dynatronics $62.56 million 0.10 -$920,000.00 ($0.21) -3.33
Motus GI $40,000.00 1,288.62 -$22.26 million ($1.23) -1.46

Dynatronics has higher revenue and earnings than Motus GI. Dynatronics is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Dynatronics has a beta of 0.02, meaning that its stock price is 98% less volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500.


This table compares Dynatronics and Motus GI’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Dynatronics -1.84% -12.16% -2.84%
Motus GI N/A -143.60% -107.10%

Analyst Recommendations

This is a summary of recent ratings for Dynatronics and Motus GI, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics 0 0 3 0 3.00
Motus GI 0 0 2 0 3.00

Dynatronics presently has a consensus price target of $3.50, indicating a potential upside of 400.00%. Motus GI has a consensus price target of $7.67, indicating a potential upside of 328.31%. Given Dynatronics’ higher probable upside, research analysts clearly believe Dynatronics is more favorable than Motus GI.


Dynatronics beats Motus GI on 8 of the 13 factors compared between the two stocks.

Dynatronics Company Profile

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.

Motus GI Company Profile

Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida.

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with's FREE daily email newsletter.